Cellectis CLLS
NASDAQ CLLS
$3.24 -0.08 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Cellectis (CLLS) Receivables (2013 - 2026)

Cellectis (CLLS) posted quarterly Receivables of $12.7 million for Q1 2026, down 44.56% year-over-year from $23.0 million in Q1 2025, and down 42.58% quarter-over-quarter from $22.2 million in Q4 2025.

Analysis

Cellectis (CLLS) Receivables (2013 - 2026) Analysis & Trends

Cellectis' Receivables history runs 14 years deep, the most recent figure standing at $12.7 million for Q1 2026.

  • In Q1 2026, Receivables fell 44.56% year-over-year to $12.7 million; the TTM figure through Mar 2026 stood at $12.7 million (down 44.56% YoY), while the FY2025 annual figure was $22.2 million, up 4.53% from the prior year.
  • Receivables for Q1 2026 stood at $12.7 million, down from $22.2 million in the prior quarter.
  • The five-year high for Receivables was $39.1 million in Q1 2024, with the low at $12.7 million in Q1 2026.
  • The 5-year median for Receivables is $21.5 million (2023), against an average of $22.1 million.
  • The sharpest annual moves came in 2022 and 2024: Receivables sank 48.52% in 2022, then soared 102.1% in 2024.
  • Cellectis' Receivables stood at $15.3 million in 2022, then soared by 40.61% to $21.5 million in 2023, then retreated by 1.09% to $21.2 million in 2024, then rose by 4.53% to $22.2 million in 2025, then slumped by 42.58% to $12.7 million in 2026.
  • Business Quant data shows CLLS's Receivables at $12.7 million in Q1 2026, $22.2 million in Q4 2025, and $24.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 2.13 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 6.57 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.93 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 160.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.06 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 912.74 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 215.33 Mn
10 Cellectis 321.90 Mn 155.05 Mn - 5.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.08 Mn
Mar 31, 2026 5.15 Mn
Dec 31, 2025 14.40 Mn
Sep 30, 2025 8.06 Mn
Jun 30, 2025 8.78 Mn
Mar 31, 2025 7.87 Mn
Dec 31, 2024 6.71 Mn
Sep 30, 2024 11.18 Mn
Jun 30, 2024 9.74 Mn
Mar 31, 2024 16.04 Mn
Dec 31, 2023 569,000.00
Sep 30, 2023 393,000.00
Jun 30, 2023 422,000.00
Mar 31, 2023 1.12 Mn
Dec 31, 2022 772,000.00
Sep 30, 2022 802,000.00
Jun 30, 2022 2.60 Mn
Mar 31, 2022 21.84 Mn
Dec 31, 2021 20.36 Mn
Sep 30, 2021 349,000.00